Multiple Sclerosis 1. 2. 3. 4. 5. 6. 7. 8.
Lucchinetti CF, Brueck W, Rodriguez M, et al., Semin Neurol, 1998;18(3):337–49.
Trapp BD, Peterson J, Ransohoff RM, et al., N Engl J Med, 1998;338(5):278–85.
Bo L, Vedeler CA, Nyland HI, et al., J Neuropathol Exp Neurol, 2003;62(7):723–32.
Babbe H, Roers A, Waisman A, et al., J Exp Med, 2000;192(3):393–404.
Ando DG, Clayton J, Kono D, et al., Cell Immunol, 1989;124(1):132–43.
Gran B, Zhang GX, Rostami A, Crit Rev Immunol, 2004;24(2):111–28.
Li H, Cuzner ML, Newcombe J, Neuropathol Appl Neurobiol, 1996;22(3):207–15.
Franciotta D, Salvetti M, Lolli F, et al., Lancet Neurol, 2008;7(9):852–8.
9. Confavreux C, Vukusic S, Bull Acad Natl Med, 2008;192(3):483.
10. Lassmann H, Curr Opin Neurol, 2008;21(3):242–7. 11. Trapp BD, Nave KA, Annu Rev Neurosci, 2008;31:247–69.
12. Giacomini PS, Darlington PJ, Bar-Or A, Curr Opin Neurol, 2009;22(3):226–32.
13. Smith ME, Stone LA, Albert PS, et al., Ann Neurol, 1993;33(5):480–89.
14. Willoughby EW, Grochowski E, Li DK, et al., Ann Neurol, 1989;25(1):43–9.
15. Vukusic S, Confavreux C, Curr Opin Neurol, 2007;20(3):269–74.
16. Compston A, Coles A, Lancet, 2008;372(9648):1502–17. 17. Polman CH, Reingold SC, Edan G, et al., Ann Neurol, 2005;58(6):840–46.
18. Tintore M, Rovira A, Martinez MJ, et al., AJNR Am J Neuroradiol, 2000;21(4):702–6.
19. Barkhof F, Filippi M, Miller DH, et al., Brain, 1997;120(Pt 11):2059–69.
20. Montalban X, Tintore M, Swanton J, et al., Neurology, 2010;74(5):427–34.
21. Thrower BW, Neurology, 2007;68(Suppl. 4):S12–15. 22. O’Riordan JI, Thompson AJ, Kingsley DP, et al., Brain, 1998;121(Pt 3):495–503.
23. Rudick RA, Arch Neurol, 1994;51(2):125–8. 24. Karpusas M, Nolte M, Benton CB, et al., Proc Natl Acad Sci U S A, 1997;94(22):11813–18.
25. Buttmann M, Rieckmann P, Expert Rev Neurother, 2007;7(3):227–39.
26. David M, BioTechniques, 2002;(Suppl. 3):58–65. 27. Rep MH, Schrijver HM, van Lopik T, et al., J Neuroimmunol, 1999;96(1):92–100.
28. Sharief MK, Semra YK, Seidi OA,J Neuroimmunol, 2001;120(1–2):199–207.
29. Kraus J, Ling AK, Hamm S, et al., Ann Neurol, 2004;56(2):192–205.
30. IFNB Multiple Sclerosis Study Group, Neurology, 1993;43(4):655–61.
31. Paty DW, Li DK, Neurology, 1993;43(4):662–7. 32. IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group, Neurology, 1995;45(7):1277–85.
33. Kappos L, Polman CH, Freedman MS, et al., Neurology, 2006;67(7):1242–9.
34. Kappos L, Freedman MS, Polman CH, et al., Lancet, 2007;370(9585):389–97.
35. European study group on interferon beta-1b in secondary progressive MS, Lancet, 1998;352(9139):1491–7.
36. Sandberg-Wollheim M, Expert Rev Neurother, 2005;5(1):25–34.
37. Jacobs LD, Cookfair DL, Rudick RA, et al., Ann Neurol, 1996;39(3):285–94.
38. Jacobs LD, Beck RW, Simon JH, et al., N Engl J Med, 2000;343(13):898–904.
39. Cohen JA, Cutter GR, Fischer JS, et al., Neurology, 2002;59(5):679–87.
40. PRISMS (Prevention of Relapses and Disability by Interferon Beta-1a Subcutaneously in Multiple Sclerosis) Study Group, Lancet, 1998;352(9139):1498–1504.
41. Li DK, Paty DW, Ann Neurol, 1999;46(2):197–206. 42. Comi G, Filippi M, Barkhof F, et al., Lancet, 2001;357(9268):1576–82.
43. Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon-Beta-1a in MS (SPECTRIMS) Study Group. Neurology, 2001;56(11):1496–1504.
44. Arnon R, Immunol Lett, 1996;50(1–2):1–15. 45. Johnson KP, Brooks BR, Cohen JA, et al., Neurology, 1995;45(7):1268–76.
46. Comi G, Filippi M, Wolinsky JS, Ann Neurol, 2001;49(3):290–97.
47. Comi G, Martinelli V, Rodegher M, et al., Lancet, 2009;374(9700):1503–11.
48. Neuhaus O, Kieseier BC, Hartung HP, Expert Rev Neurother, 2004;4(1):17–26.
49. Vollmer T, Stewart T, Baxter N, Neurology, 2010;74 (Suppl. 1):S41–6.
50. Hartung HP, Gonsette R, Konig N, et al., Lancet, 2002;360(9350):2018–25.
51. Edan G, Miller D, Clanet M, et al., J Neurol Neurosurg Psychiatry, 1997;62(2):112–18.
52. Pattoneri P, Sozzi F, Pela G, et al., Echocardiography, 2009;26(4):397–402.
53. Pascual AM, Tellez N, Bosca I, et al., Mult Scler, 2009;15(11):1303–10.
54. Stuve O, Gold R, Chan A, et al., J Neurol, 2008;255(Suppl. 6):58–65.
55. Ransohoff RM, N Engl J Med, 2007;356(25):2622–9. 56. Polman CH, O’Connor PW, Havrdova E, et al., N Engl J Med, 2006;354(9):899–910.
57. Rudick RA, Stuart WH, Calabresi PA, et al., N Engl J Med, 2006;354(9):911–23.
58. Kleinschmidt-DeMasters BK, Tyler KL, N Engl J Med, 2005;353(4):369–74.
59. Van Assche G, Van Ranst M, Sciot R, et al., N Engl J Med, 2005;353(4):362–8.
60. Langer-Gould A, Atlas SW, Green AJ, et al., N Engl J Med, 2005;353(4):375–81.
61. Clifford DB, De Luca A, Simpson DM, et al., Lancet Neurol, 2010;9(4):438–46.
62. Khatri BO, Man S, Giovannoni G, et al., Neurology, 2009;72(5):402–9.
63. Huang D, Cossoy M, Li M, et al., Ann Neurol, 2007;62(1):34–9.
64. Casetta I, Iuliano G, Filippini G, Cochrane Database Syst Rev, 2007;(4)(4):CD003982.
65. Rinaldi L, Perini P, Calabrese M, Neurol Sci, 2009;30(Suppl. 2):S171–3.
66. Gray O, McDonnell GV, Forbes RB, Cochrane Database Syst Rev, 2004;(2)(2):CD003208.
67. Neuhaus O, Kieseier BC, Hartung HP, Neurotherapeutics, 2007;4(4):654–60.
68. Goodman AD, Brown TR, Krupp LB, et al., Lancet, 2009;373(9665):732–8.
69. Brinkmann V, Davis MD, Heise CE, et al., J Biol Chem, 2002;277(24):21453–7.
70. Cohen JA, Barkhof F, Comi G, et al., N Engl J Med, 2010;362(5):402–15.
71. Beutler E, Lancet, 1992;340(8825):952–6. 72. Giovannoni G, Comi G, Cook S, et al., N Engl J Med, 2010;362(5):416–26.
73. Moharregh-Khiabani D, Linker RA, Gold R, et al., Curr Neuropharmacol, 2009;7(1):60–64.
74. Hauser SL, Waubant E, Arnold DL, et al., N Engl J Med, 2008;358(7):676–88.
75. O’Connor PW, Li D, Freedman MS, et al., Neurology, 2006;66(6):894–900.
76. Coles AJ, Compston DA, Selmaj KW, et al., N Engl J Med, 2008;359(17):1786–1801.
77. Rose JW, Burns JB, Bjorklund J, et al., Neurology, 2007;69(8):785–9.
82
EUROPEAN NEUROLOGICAL REVIEW
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116